您当前所在的位置:首页 > 产品中心 > 产品详细信息
28657-80-9 分子结构
点击图片或这里关闭

1-ethyl-4-oxo-1H,4H,7H-[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid

ChemBase编号:706
分子式:C12H10N2O5
平均质量:262.2182
单一同位素质量:262.05897143
SMILES和InChIs

SMILES:
O1c2cc3n(nc(c(=O)c3cc2OC1)C(=O)O)CC
Canonical SMILES:
CCn1nc(C(=O)O)c(=O)c2c1cc1OCOc1c2
InChI:
InChI=1S/C12H10N2O5/c1-2-14-7-4-9-8(18-5-19-9)3-6(7)11(15)10(13-14)12(16)17/h3-4H,2,5H2,1H3,(H,16,17)
InChIKey:
VDUWPHTZYNWKRN-UHFFFAOYSA-N

引用这个纪录

CBID:706 http://www.chembase.cn/molecule-706.html

Collapse All Expand All

名称和登记号

名称和登记号

名称 登记号
IUPAC标准名
1-ethyl-4-oxo-1H,4H,7H-[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid
IUPAC传统名
cinoxacin
商标名
Cinobac
别名
Cinoxacin
Cinoxacin
CAS号
28657-80-9
EC号
249-133-8
MDL号
MFCD00056776
PubChem SID
46507547
24278343
160964169
PubChem CID
2762

数据来源

数据来源

所有数据来源 商品来源 非商品来源

理论计算性质

理论计算性质

JChem ALOGPS 2.1
Acid pKa 4.930532  质子受体
质子供体 LogD (pH = 5.5) 1.0434979 
LogD (pH = 7.4) -0.71855384  Log P 1.7161168 
摩尔折射率 73.6022 cm3 极化性 23.858301 Å3
极化表面积 88.43 Å2 可自由旋转的化学键
里宾斯基五规则 true 
Log P 1.25  LOG S -2.44 
溶解度 9.61e-01 g/l 

分子性质

分子性质

理化性质 安全信息 药理学性质 产品相关信息 生物活性(PubChem)
疏水性(logP)
1.5 expand 查看数据来源
RTECS编号
JI4640000 expand 查看数据来源
德国WGK号
2 expand 查看数据来源
个人保护装置
Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter expand 查看数据来源
作用靶点
Others expand 查看数据来源
成盐信息
Free Base expand 查看数据来源

详细说明

详细说明

DrugBank DrugBank Sigma Aldrich Sigma Aldrich
DrugBank -  DB00827 external link
Item Information
Drug Groups approved
Description Synthetic antimicrobial related to oxolinic acid and nalidixic acid and used in urinary tract infections. [PubChem]
Indication For the treatment of initial and recurrent urinary tract infections in adults caused by the following susceptible microorganisms: Escherichia coli, Proteus mirabilis, Proteus vulgaris, Klebsiella species (including K. pneumoniae), and Enterobacter species.
Pharmacology Cinoxacin is a synthetic antibacterial agent with in vitro activity against many gram-negative aerobic bacteria, particularly strains of the Enterobacteriaceae family. Cinoxacin inhibits bacterial deoxyribonucleic acid (DNA) synthesis, is bactericidal, and is active over the entire urinary pH range. Cross resistance with nalidixic acid has been demonstrated.
Toxicity Oral, subcutaneous, and intravenous LD50 in the rat is 3610 mg/kg, 1380 mg/kg, and 860 mg/kg, respectively. Oral, subcutaneous, and intravenous LD50 in the mouse is 2330 mg/kg, 900 mg/kg, and 850 mg/kg, respectively.Symptoms following an overdose of cinoxacin may include anorexia, nausea, vomiting, epigastric distress, and diarrhea. The severity of the epigastric distress and the diarrhea are dose related. Headache, dizziness, insomnia, photophobia, tinnitus, and a tingling sensation have been reported in some patients.
Affected Organisms
Enteric bacteria and other eubacteria
Biotransformation Hepatic, with approximately 30-40% metabolized to inactive metabolites.
Absorption Rapidly absorbed after oral administration. The presence of food delays absorption but does does not affect total absorption.
Half Life The mean serum half-life is 1.5 hours. Half-life in patients with impaired renal function may exceed 10 hours.
Protein Binding 60 to 80%
External Links
Wikipedia
RxList
Drugs.com
Sigma Aldrich -  C8645 external link
Application
Cinoxacin is a synthetic antimicrobial commonly used in urinary tract infections that are caused by Escherichia coli, Proteus mirabilis, Proteus vulgaris, Klebsiella species, and Enterobacter species.. It is a quinolone gyrase inhibitor. It is used to study the rat renal organic anion transporter 1 (OAT1)1. It is used to study fluoroquinolone-resistant Streptococcus pyogenes2.
Biochem/physiol Actions
Cinoxacin interferes with DNA replication by inhibiting DNA gyrase and topoisomerase IV (topo IV) through tight DNA binding. Cinoxacin allows for proper replicated DNA separation. Therefore, the inhibition of Cinoxacin inhibits DNA replication and cell division.
Cinoxacin interferes with DNA replication by inhibiting DNA gyrase and topoisomerase IV (topo IV) through tight DNA binding.
Other Notes
Tandem Mass Spectrometry data independently generated by Scripps Center for Metabolomics is available to view or download in PDF. C8645.pdf Tested metabolites are featured on Scripps Center for Metabolomics METLIN Metabolite Database. To learn more, visit sigma.com/metlin.

参考文献

参考文献

供应商提供 Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
    暂无数据
正在搜索,请耐心等待...(如果遇到网页错误或者长时间没有结果,请刷新页面[F5])

专利

专利

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

互联网资源

互联网资源

百度图标百度 google iconGoogle